These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33201403)

  • 1. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma.
    Chen MF; Lu MS; Hsieh CC; Chen WC
    Cell Oncol (Dordr); 2021 Apr; 44(2):373-384. PubMed ID: 33201403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Xu HJ; Qi YJ; Wu DR; Liu QW; Chen P; Li MX; Jiao YL; Ruan HJ; Li ZT; Gao SG
    Zhonghua Zhong Liu Za Zhi; 2024 Aug; 46(8):746-754. PubMed ID: 39143797
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.
    Qi YJ; Jiao YL; Chen P; Kong JY; Gu BL; Liu K; Feng DD; Zhu YF; Ruan HJ; Lan ZJ; Liu QW; Mi YJ; Guo XQ; Wang M; Liang GF; Lamont RJ; Wang H; Zhou FY; Feng XS; Gao SG
    PLoS Biol; 2020 Sep; 18(9):e3000825. PubMed ID: 32886690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of
    Guo Y; Liu Y; Yang H; Dai N; Zhou F; Yang H; Sun W; Kong J; Yuan X; Gao S
    Pathol Oncol Res; 2021; 27():1609976. PubMed ID: 34955686
    [No Abstract]   [Full Text] [Related]  

  • 5. Porphyromonas gingivalis promotes the motility of esophageal squamous cell carcinoma by activating NF-κB signaling pathway.
    Meng F; Li R; Ma L; Liu L; Lai X; Yang D; Wei J; Ma D; Li Z
    Microbes Infect; 2019; 21(7):296-304. PubMed ID: 30763763
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liang G; Wang H; Shi H; Zhu M; An J; Qi Y; Du J; Li Y; Gao S
    ACS Infect Dis; 2020 May; 6(5):871-881. PubMed ID: 32298082
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wang X; Jia Y; Wen L; Mu W; Wu X; Liu T; Liu X; Fang J; Luan Y; Chen P; Gao J; Nguyen KA; Cui J; Zeng G; Lan P; Chen Q; Cheng B; Wang Z
    Cancer Res; 2021 May; 81(10):2745-2759. PubMed ID: 34003774
    [No Abstract]   [Full Text] [Related]  

  • 8. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy.
    Gao S; Liu Y; Duan X; Liu K; Mohammed M; Gu Z; Ren J; Yakoumatos L; Yuan X; Lu L; Liang S; Li J; Scott DA; Lamont RJ; Zhou F; Wang H
    Br J Cancer; 2021 Aug; 125(3):433-444. PubMed ID: 33981017
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wen L; Mu W; Lu H; Wang X; Fang J; Jia Y; Li Q; Wang D; Wen S; Guo J; Dai W; Ren X; Cui J; Zeng G; Gao J; Wang Z; Cheng B
    J Dent Res; 2020 Jun; 99(6):666-675. PubMed ID: 32298192
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jia X; Liu J; He Y; Huang X
    Front Cell Infect Microbiol; 2022; 12():982636. PubMed ID: 36262185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
    Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
    Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
    Lan Z; Zou KL; Cui H; Zhao YY; Yu GT
    Mol Oncol; 2024 May; 18(5):1174-1188. PubMed ID: 37666495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
    Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
    Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral infection with a periodontal pathogen alters oral and gut microbiomes.
    Simas AM; Kramer CD; Weinberg EO; Genco CA
    Anaerobe; 2021 Oct; 71():102399. PubMed ID: 34090994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs.
    Ha NH; Park DG; Woo BH; Kim DJ; Choi JI; Park BS; Kim YD; Lee JH; Park HR
    Cytokine; 2016 Oct; 86():64-72. PubMed ID: 27468958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
    BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma.
    Lamont RJ; Fitzsimonds ZR; Wang H; Gao S
    Periodontol 2000; 2022 Jun; 89(1):154-165. PubMed ID: 35244980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties.
    Ha NH; Woo BH; Kim DJ; Ha ES; Choi JI; Kim SJ; Park BS; Lee JH; Park HR
    Tumour Biol; 2015 Dec; 36(12):9947-60. PubMed ID: 26178482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment.
    Guo ZC; Jing SL; Jia XY; Elayah SA; Xie LY; Cui H; Tu JB; Na SJ
    Inflamm Res; 2024 May; 73(5):693-705. PubMed ID: 38150024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.